Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.610
-0.600 (-14.25%)
Nov 16, 2026, 4:00 PM EST - Market closed

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $385.17 million as of November 16, 2026. It is the 16,040th most valuable company in the world and the 2,895th biggest in the United States. Its market cap has increased by 32.95% in one year.

Market Cap
385.17M
Enterprise Value
183.05M
1-Year Change
32.95%
Global Rank
Country Rank
#2,895 United States
Category

Chart

Chart

Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $385.17M, an increase of 580.51%. That is a compound annual growth rate of 18.79%.

History

DateMarket Cap% Change
Nov 16, 2026385.17M8.74%
Dec 31, 2025354.20M2,156.05%
Dec 31, 202415.70M-87.40%
Dec 29, 2023124.60M18.67%
Dec 30, 2022105.00M-73.42%
Dec 31, 2021395.00M-24.17%
Dec 31, 2020520.90M30.00%
Dec 31, 2019400.70M1,125.38%
Dec 31, 201832.70M247.87%
Dec 29, 20179.40M-28.24%
Dec 30, 201613.10M-54.67%
Dec 31, 201528.90M-48.94%
Sep 30, 201556.60M-
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding